
A $1 Trillion Gap: Where FemTech Founders Fit in Qatar as QSTP and Merck Showcase Pilots
- by Falak
Women spend 25% more of their lives in poor health than men, and closing that gap could add at least $1 trillion a year to the global economy by 2040, according to the McKinsey Health Institute. Yet the same research finds FemTech companies received just 3% of total digital-health funding. That mismatch between need and capital is exactly where founders and investors find opportunity, and Qatar now has a structured route into it: the QSTP × Merck FemTech Accelerator, whose 30-startup cohort has its final showcase scheduled for November.
The McKinsey Health Institute report, published in January 2024, sets out why women's health is a market and not a niche:
For founders, the takeaway is that the problem is large, the evidence base is thin, and capital has not yet caught up. For investors, under-allocation of this kind is often where returns come from, though, as with any sector thesis, that is a judgment rather than a guarantee.
According to QSTP's programme page, the accelerator brings together 30 FemTech startups in a multi-phase, hybrid format with pilot opportunities across Qatar and the WANA region. Key terms:
The programme targets deep-tech startups, including AI, robotics and material science, addressing women's health across areas such as cardiovascular and autoimmune conditions, mental health, chronic disease in women, diagnostics, digital health and fertility. Applicants were expected to show a scalable model, traction such as revenue, pilots, partnerships or users, and readiness to operate in WANA. Startups could apply from anywhere in the world.
The published timeline ran from a global online intake in April–May, through a Doha immersion in June and pilot execution from July to November, with a regional expansion stop in Egypt in September–October. The final showcase and roadshow, presenting pilot outcomes to leaders and investors, is scheduled for November in Doha. Applications for this cohort closed on 25 March.
Reading the McKinsey evidence alongside the accelerator's focus list suggests several areas where Qatar-based founders could build. This is general guidance rather than a ranking:
TrialHer, a member of the current cohort, shows how a startup can use the programme to approach Qatar's health system. As profiled by QSTP on 10 November 2026, the Geneva-headquartered company, founded by CEO Hyatt Antognini-Amin, works to involve women in shaping medical research, not only enrolling them once a study is designed.
The company's own survey of more than 500 women found that over 70% had never been invited to take part in health research, and 91% said they would help co-design research if their time were fairly valued. These are TrialHer's figures, not an independent study.
Through the accelerator, TrialHer is exploring a regional base in Doha. QSTP describes a proposed pilot with Weill Cornell Medicine-Qatar, still under exploration, that would involve up to 100 women and focus on gestational diabetes and the factors that influence women's participation in research. The lesson for other founders is the shape of the approach: a defined condition, a credible clinical partner, a small and measurable cohort, and a clear research question. Its founder's advice is practical: "Involve women while there is still room for their input to change what you're building."
The human development pillar of Qatar National Vision 2030 centres on learning and healthcare, and the economic pillar aims for a varied, competitive economy. FemTech sits where the two meet: it can improve health outcomes for women in Qatar while building a knowledge-based industry that exports to the wider region. Programmes that offer patient access, data access and lab facilities to startups help turn that alignment into real companies. For the wider health context, see After QMED 2026: Where Healthtech Startups Fit in Qatar's National Health Strategy.
Photo: Tima Miroshnichenko / Pexels
Share:
Won the Hackathon, Now What? Turning a Weekend Prototype into a Qatar Startup
Bootstrapped, Paying, Then Incubated: What CloudZigo's QSTP Move Teaches Founders